|
1
|
Papagheorghe R: Bloodstream infections in
immunocompromised hosts. Roum Arch Microbiol Immunol. 71:87–94.
2012.PubMed/NCBI
|
|
2
|
Samonis G, Vardakas KZ, Maraki S, Tansarli
GS, Dimopoulou D, Kofteridis DP, Andrianaki AM and Falagas ME: A
prospective study of characteristics and outcomes of bacteremia in
patients with solid organ or hematologic malignancies. Support Care
Cancer. 21:2521–2526. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bassetti M, Righi E and Viscoli C:
Pseudomonas aeruginosa serious infections: Mono or combination
antimicrobial therapy? Curr Med Chem. 15:517–522. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garnacho-Montero J, Sa-Borges M,
Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A
and Rello J: Optimal management therapy for Pseudomonas aeruginosa
ventilator-associated pneumonia: An observational, multicenter
study comparing monotherapy with combination antibiotic therapy.
Crit Care Med. 35:1888–1895. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Micek ST, Lloyd AE, Ritchie DJ, Reichley
RM, Fraser VJ and Kollef MH: Pseudomonas aeruginosa bloodstream
infection: Importance of appropriate initial antimicrobial
treatment. Antimicrob Agents Chemother. 49:1306–1311. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paul M, Benuri-Silbiger I, Soares-Weiser K
and Leibovici L: Beta lactam monotherapy versus beta
lactam-aminoglycoside combination therapy for sepsis in
immunocompetent patients: Systematic review and meta-analysis of
randomised trials. BMJ. 328:6682004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morata L, Cobos-Trigueros N, Martínez JA,
Soriano A, Almela M, Marco F, Sterzik H, Núñez R, Hernández C and
Mensa J: Influence of multidrug resistance and appropriate
empirical therapy on the 30-day mortality rate of Pseudomonas
aeruginosa bacteremia. Antimicrob Agents Chemother. 56:4833–4837.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Micek ST, Welch EC, Khan J, Pervez M,
Doherty JA, Reichley RM and Kollef MH: Empiric combination
antibiotic therapy is associated with improved outcome against
sepsis due to Gram-negative bacteria: A retrospective analysis.
Antimicrob Agents Chemother. 54:1742–1748. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anderson ET, Young LS and Hewitt WL:
Antimicrobial synergism in the therapy of gram-negative rod
bacteremia. Chemotherapy. 24:45–54. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chamot E, Boffi El Amari E, Rohner P and
Van Delden C: Effectiveness of combination antimicrobial therapy
for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother.
47:2756–2764. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bliziotis IA, Petrosillo N, Michalopoulos
A, Samonis G and Falagas ME: Impact of definitive therapy with
beta-lactam monotherapy or combination with an aminoglycoside or a
quinolone for Pseudomonas aeruginosa bacteremia. PLoS One.
6:e264702011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bowers DR, Liew YX, Lye DC, Kwa AL, Hsu LY
and Tam VH: Outcomes of appropriate empiric combination versus
monotherapy for Pseudomonas aeruginosa bacteremia. Antimicrob
Agents Chemother. 57:1270–1274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deconinck L, Meybeck A, Patoz P, Van
Grunderbeeck N, Boussekey N, Chiche A, Delannoy PY, Georges H and
Leroy O: Impact of combination therapy and early de-escalation on
outcome of ventilator-associated pneumonia caused by Pseudomonas
aeruginosa. Infect Dis (Lond). 49:396–404. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Paulsson M, Granrot A, Ahl J, Tham J,
Resman F, Riesbeck K and Månsson F: Antimicrobial combination
treatment including ciprofloxacin decreased the mortality rate of
Pseudomonas aeruginosa bacteraemia: A retrospective cohort study.
Eur J Clin Microbiol Infect Dis. 36:1187–1196. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siegman-Igra Y, Ravona R, Primerman H and
Giladi M: Pseudomonas aeruginosa bacteremia: An analysis of 123
episodes, with particular emphasis on the effect of antibiotic
therapy. Int J Infect Dis. 2:211–215. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim YJ, Jun YH, Yang RK, Park KG, Park YJ,
Kang JY and Kim SI: Risk factors for mortality in patients with
Pseudomonas aeruginosa bacteremia; retrospective study of impact of
combination antimicrobial therapy. BMC Infect Dis. 14:1612014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Samonis G, Vardakas KZ, Kofteridis DP,
Dimopoulou D, Andrianaki AM, Chatzinikolaou I, Katsanevaki E,
Maraki S and Falagas ME: Characteristics, risk factors and outcomes
of adult cancer patients with extensively drug-resistant
Pseudomonas aeruginosa infections. Infection. 42:721–728. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peña C, Suarez C, Ocampo-Sosa A, Murillas
J, Almirante B, Pomar V, Aguilar M, Granados A, Calbo E,
Rodríguez-Baño J, et al: Effect of adequate single-drug vs
combination antimicrobial therapy on mortality in Pseudomonas
aeruginosa bloodstream infections: A post Hoc analysis of a
prospective cohort. Clin Infect Dis. 57:208–216. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hilf M, Yu VL, Sharp J, Zuravleff JJ,
Korvick JA and Muder RR: Antibiotic therapy for Pseudomonas
aeruginosa bacteremia: Outcome correlations in a prospective study
of 200 patients. Am J Med. 87:540–546. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leibovici L, Paul M, Poznanski O, Drucker
M, Samra Z, Konigsberger H and Pitlik SD: Monotherapy versus
beta-lactam-aminoglycoside combination treatment for gram-negative
bacteremia: A prospective, observational study. Antimicrob Agents
Chemother. 41:1127–1133. 1997.PubMed/NCBI
|
|
21
|
Kuikka A and Valtonen VV: Factors
associated with improved outcome of Pseudomonas aeruginosa
bacteremia in a Finnish university hospital. Eur J Clin Microbiol
Infect Dis. 17:701–708. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mendelson MH, Gurtman A, Szabo S, Neibart
E, Meyers BR, Policar M, Cheung TW, Lillienfeld D, Hammer G, Reddy
S, et al: Pseudomonas aeruginosa bacteremia in patients with AIDS.
Clin Infect Dis. 18:886–895. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park SY, Park HJ, Song MM, Park KH, Chong
YP, Kim MN, Kim SH, Lee SO, Kim YS, Woo JH and Choi SH: Impact of
adequate empirical combination therapy on mortality from bacteremic
Pseudomonas aeruginosa pneumonia. BMC Infect Dis. 12:3082012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoon YK, Kim HA, Ryu SY, Lee EJ, Lee MS,
Kim J, Park SY, Yang KS and Kim SW; Antibiotic Stewardship
StudyGroup, : Tree-structured survival analysis of patients with
Pseudomonas aeruginosa bacteremia: A multicenter observational
cohort study. Diagn Microbiol Infect Dis. 87:180–187. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tan SH, Teng CB, Ng TM and Lye DC:
Antibiotic therapy and clinical outcomes of Pseudomonas aeruginosa
(PA) bacteraemia. Ann Acad Med Singapore. 43:526–534.
2014.PubMed/NCBI
|
|
26
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang WS, Va P, Wong MY, Zhang HL and Xiang
YB: Soy intake is associated with lower lung cancer risk: Results
from a meta-analysis of epidemiologic studies. Am J Clin Nutr.
94:1575–1583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Y, Zhang D, Feng N, Chen G, Liu J,
Chen G and Zhu Y: Increased intake of vegetables, but not fruit,
reduces risk for hepatocellular carcinoma: A meta-analysis.
Gastroenterology. 147:1031–1042. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Zheng QJ, Wang S, Zeng SX, Zhang
YP, Bai XJ and Hou TY: Diabetes mellitus is associated with
increased risk of surgical site infections: A meta-analysis of
prospective cohort studies. Am J Infect Control. 43:810–815. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gu WJ, Wang F, Tang L and Liu JC:
Single-dose etomidate does not increase mortality in patients with
sepsis: A systematic review and meta-analysis of randomized
controlled trials and observational studies. Chest. 147:335–346.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ownby RL, Crocco E, Acevedo A, John V and
Loewenstein D: Depression and risk for Alzheimer disease:
Systematic review, meta-analysis, and metaregression analysis. Arch
Gen Psychiatry. 63:530–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lo CK, Mertz D and Loeb M:
Newcastle-Ottawa Scale: Comparing reviewers' to authors'
assessments. BMC Med Res Methodol. 14:452014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Larsson SC, Orsini N and Wolk A: Vitamin
B6 and risk of colorectal cancer: A meta-analysis of prospective
studies. JAMA. 303:1077–1083. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Higgins JP and Green S: Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0. The Cochrane
Collaboration; 2011, http://handbook.cochrane.orgMarch. 2011
|
|
36
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sterne JA and Egger M: Funnel plots for
detecting bias in meta-analysis: Guidelines on choice of axis. J
Clin Epidemiol. 54:1046–1055. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Traugott KA, Echevarria K, Maxwell P,
Green K and Lewis JS II: Monotherapy or combination therapy? The
Pseudomonas aeruginosa conundrum. Pharmacotherapy. 31:598–608.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chatzinikolaou I, Abi-Said D, Bodey GP,
Rolston KV, Tarrand JJ and Samonis G: Recent experience with
Pseudomonas aeruginosa bacteremia in patients with cancer:
Retrospective analysis of 245 episodes. Arch Intern Med.
160:501–509. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Safdar N, Handelsman J and Maki DG: Does
combination antimicrobial therapy reduce mortality in Gram-negative
bacteraemia? A meta-analysis. Lancet Infect Dis. 4:519–527. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Y, Chen XL, Huang AW, Liu SL, Liu
WJ, Zhang N and Lu XZ: Mortality attributable to
carbapenem-resistant Pseudomonas aeruginosa bacteremia: A
meta-analysis of cohort studies. Emerg Microbes Infect. 5:e272016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vardakas KZ, Tansarli GS, Bliziotis IA and
Falagas ME: β-Lactam plus aminoglycoside or fluoroquinolone
combination versus β-lactam monotherapy for Pseudomonas aeruginosa
infections: A meta-analysis. Int J Antimicrob Agents. 41:301–310.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hu Y, Li L, Li W, Xu H, He P, Yan X and
Dai H: Combination antibiotic therapy versus monotherapy for
Pseudomonas aeruginosa bacteraemia: A meta-analysis of
retrospective and prospective studies. Int J Antimicrob Agents.
42:492–496. 2013. View Article : Google Scholar : PubMed/NCBI
|
